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Abstract
Background: Mineral Pitch (MP) is a dark brown coloured humic matter originating from high altitude rocks. It is
an Ayurvedic medicinal food, commonly used by the people of the Himalayan regions of Nepal and India for
various body ailments.
Methods: The Huh-7 cells were treated with different concentrations of MP for 24 h, and both apoptosis and
proliferation was determined by the TUNEL and MTT assays respectively. The formation of ROS and nitric oxide was
analysed by DCFH-DA and Griess reagent respectively. The expression of miRNA-21 and miRNA-22 were checked by
the real time PCR. Effect of miRNA-22 on proliferation and c-myc was studied by over-expressing miRNA-22 premiRs
in Huh-7 cells.
Results: We found that MP enhanced anti-cancer effects by inducing apoptosis and inhibiting proliferation. MP
induced both ROS and NO, upon neutralizing them, there was a partial recovery of apoptosis and proliferation. MP
also induced miRNA-22 expression, while miRNA-21 expression was inhibited. Over-expression of miRNA-22 resulted
in a significant inhibition of proliferation. miRNA-22 directly targeted c-myc gene, thereby inhibited proliferation.
These results clearly show that MP induces its anti-cancer activity by more than one pathway.
Conclusion: The data clearly indicate that MP induced apoptosis via the production of ROS, and inhibited
proliferation by inducing miRNA-22 and inhibiting miRNA-21 in Huh-7 cells.
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Background
Hepatocellular Carcinoma (HCC) is a complex form of
neoplasm, associated with many risk factors such as,
Hepatitis B and C virus infection, non-alcoholic fatty
liver disease (NAFLD), alcohol abuse, aflatoxins, dia-
betes, obesity, and genetic factors [1]. HCC is the third
leading cause of death among the cancer-related prob-
lems, and the prime cause of mortality among the cir-
rhosis patients [2].
Surgical resection is the best therapeutic preference
for non-malignant primary liver tumour. The number of
patients who undergo liver transplants are very less,
which is due to the long waiting list, less number of
transplant surgeons, donor availability problems and
high cost. Several chemotherapeutic drugs have been
assayed for the treatment of HCC [1]. However, success
has been achieved only in few patients, or some with in-
equitable response. The major scientific challenge
against HCC is the limited response to the available
chemotherapy and the development of resistance during
the treatment. Resistance to chemotherapy may be due
to an improved DNA repair capacity and greatly acti-
vated antioxidant enzymes in the cancer cells. HCC is
considered highly resistant to the therapeutic agents,
leading to the DNA damage [1].
Approximately, 50 % of the modern anticancer drugs
used in the cancer chemotherapy have been originated
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from the natural products. Hence, the use of natural
products in the development of new drugs has been a
great interest for researchers.
Recently several work has been done with Traditional
Chinese Medicine (TCM) for the treatment of cancer.
TCM has been used as adjuvant therapy to inhibit can-
cer, when Western medicines cannot provide any treat-
ment options. TCM is used in conjunction with
chemotherapy and radiotherapy for inhibiting the toxic
effects of the treatments, as well as improving overall ef-
ficacy [3, 4].
Mineral Pitch (MP), also called as shilajit in local
vernacular, is a dark brown coloured humic matter
that drips out of the high altitude rocks (above
1000 m) during summer months. It is believed that it
can cure almost all body ailments [5–7]. MP is a nat-
ural medicinal food, mainly used to treat people with
weakness, inflammation, bone fracture, bleeding and
for wound healing [6]. Since there is an insufficient
number of medical facilities, eighty percent of total
population mostly rely on the natural products for
their primary health care needs [8].
MP is a humic matter, shown to contain fulvic acid
and humic acid, which are responsible for its biochem-
ical activities. In some previous studies humic matter
has been reported to be anticancer agent as it inhibited
the cancer cell growth and induced the apoptosis [9].
Moreover the cytotoxic properties of humic acid was ac-
companied the ROS production [10] and NO synthesis
[11]. MP has been reported to be useful in reducing in-
flammation, arthritis, rheumatism, pain, ulcer, anxiety,
stress, and diabetes [6]. Recently, MP also has been re-
ported as an antiviral agent against Herpes Simplex
Virus (HSV) [12] however, many of its other potential
functions including its effects on cancer, has not been
studied so far.
In this study, the anticancer property of MP was
determined in hepatic cancer cells. It is an essential
ethno-medicinal food, has large demand due to many
therapeutic benefits in remedial recipes. Since a large
population of Nepal and India customarily consume MP,
the present investigation might have some implication in
understanding its therapeutic significance in HCC
management.
Methods
Collection of Mineral Pitch (MP)
MP was collected from the village Matela, Baitadi dis-
trict of far-western Nepal, from the local inhabitants.
This drug was transported to the laboratory in a clean
and sterile bag. The stock solution was made by dissolv-
ing 2 mg/ml in double distilled water and was stored
after filtering with 0.44 μm membrane filter and used for
all the experiments.
Cell culture and MP treatment
Huh-7 cells (1 × 106) were cultured in 6-well plates using
Dulbecco's modified Eagle's medium (DMEM) (Life
Technologies, Carlsbad, USA) supplemented with 10 %
fetal bovine serum (FBS) and 1 % penicillin/strepto-
mycin. After 24 h, the cells were cultured in serum-free
media and further incubated with different concentra-
tions (0, 10, 20, 50, 100, 500, and 1000 μg/ml) of MP for
24 h. After incubation, the cells were washed and col-
lected either for various assays, RNA isolation for RT-
PCR or Western blots.
ROS and NO neutralization experiments
Huh-7 cells were cultured in 6-well plates and the
medium was replaced with serum-free media and the
cells were incubated with MP (0, 50 and 100 μg/ml) for
a period of 24 h. For ROS and NO neutralizing experi-
ments, once the cells were replenished with serum-free
media, the cells were pre-incuated with either N-acetyl
cysteine (NAC, 5 mM) or L-NG-Nitroarginine methyl
ester (L-NAME, 10 μM) for 1 h followed by the addition
of MP (100 μg/ml) for a further period of 24 h. After the
incubation, the cells were washed with PBS and were
dissociated using PBS-2 mM EDTA and then stained
with Annexin V or PI. Immediately the positive cells
were counted using flow cytometry and the apoptosis in-
duction was calculated.
Cell viability assay
Huh-7 cells (5 × 103 cells per well) were plated in 96-
well plates. After 24 h the media was replaced with
serum-free media along with various concentrations of
MP for a further period of 24 h. MTT reagent (10 μl;
5 mg/ml) solution was added to each well and the plates
were incubated at 37 °C for 1 h. The medium was re-
moved, 100 μl of DMSO was added to each well and
mixed for 5 min. The absorbance was measured at
570 nm and the untreated control cells were considered
as 100 % of cell survival. The following formula was ap-
plied to calculate the cell viability [13].




The 2.0 × 103 cells were seeded in 60 mm cell culture-
treated dishes, along with the various concentrations of
the MP (10–1000 μg/ml). The cells were incubated for
6 days, with a change of media and MP at every 24 h. At
the end of 6 days, 0.5 % crystal violet dissolved in etha-
nol was used to stain the cells and the data were calcu-
lated [14].
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TUNEL assay
The cells were cultured in 6-well plates with various
treatments. After the incubation, TUNEL assay was
performed using in situ cell death detection kit (Roche
Diagnostics, USA) as described by us previously [15].
The percentage of cell death was calculated by following
formula:
Percentof apoptoticcells ¼ TUNELpositivecells=Total cell count 100½ :
ROS determination
Huh-7 cells were cultured (5 × 105 cells/well) for 24 h
and the media was replaced with serum-free media
along with different concentrations of MP for a further
period of 24 h. A solution of 2’,7’-dihydrochloroflurores-
cein acetate (DCFH-DA) (10 μM) was added to the cells
and incubated for 60 min in dark. After staining, the
cells were collected using PBS containing 2 mM EDTA.
The fluorescence of DCFH-DA labelled cells were exam-
ined using flow cytometry analysis.
NO determination
The cells (5 × 105 cells per well) were incubated with dif-
ferent concentration of MP for 24 h. After the incuba-
tion, the media was collected and used for the
estimation of the production of NO using Nitrate/Nitrite
Colorimetric Assay Kit (Cayman, USA) as per the manu-
facturer’s instructions. The percent of nitrite production
was calculated against untreated control.
Lipid peroxidation assay
After the MP treatment, the cells (5 × 105 cells per well)
were lysed. The homogenate (1 ml) was mixed with
0.15 M Tris–Cl buffer (pH 7.4), 10 % trichloroacetic
(TCA) and 50 mM thiobarbituric acid (TBA). This mix-
ture was heated for 30 min at 80 °C, cooled and centri-
fuged for 10 min at 3000 rpm. The absorbance of the
supernatant was measured against the blank (distilled
water) at 530 nm in a UV spectrophotometer and MDA
formed in the cells was determined.
Assay for cellular antioxidant enzymes
The cells were incubated with different concentration of
MP. After the incubation, reduced glutathione (GSH),
catalase and SOD activity assays were performed accord-
ing to the methods described previously [16, 17]. The
total cellular protein content was estimated using BCA
reagent (Thermo Scientific, USA) as per the manufac-
turer’s instructions. The protein content was used for
the calculation of the enzyme activities.
RNA isolation, cDNA synthesis, and Real-time PCR
Total RNA enriched with miRNA was extracted from
Huh-7 cells using the mirVana miRNA isolation kit (Life
Technologies, Carlsbad, CA, USA), following the manu-
facturer’s instructions. Reverse transcription was per-
formed using the Universal cDNA synthesis kit (Exiqon,
Vedbaek, Denmark). RT-PCR was done with SYBR
Green and PCR master mix (Life Technologies). Cyber-
green method was used for the real-time PCR using
specific primers for both miRNA-21 and miRNA-22,
and 5S RNA was used as an internal control as de-
scribed previously [18, 19]. Each PCR was performed in
duplicates and the data were normalized with endogen-
ous 5S RNA levels. Relative expression were calculated
using 2-ΔΔct values. All the experiments were repeated at
least three times in triplicates.
MiRNA-22 transfection experiments
Huh-7 cells cells (3.5 × 105 cells/well) were plated in 6-
well plates and transfected with either miRNA-22
(10nM) or a non-specific miRNA (10nM; a miRNA
which does not inhibit any known mRNA) (Sigma Al-
drich, USA) using siPORT miRNA transfection reagent
(Invitrogen, USA) as per the manufacturer’s instructions.
In parallel, the cells were transfected with fluorescein
conjugated siRNA to check the transfection efficiency.
After 24 h, the media was changed and allowed to grow
for 48 h and then the cells were collected either for
RNA isolation or protein isolation.
Protein isolation and Western blot analysis
After 72 h of transfection, the total cellular protein was
isolated from the transfected cells using mammalian
protein extraction buffer (Thermo Scientific, USA). Pro-
tein concentration was estimated using bicinconinic acid
(BCA) protein estimation kit (Thermo Scientific). Sam-
ples (60 μg/lane) were run on a 12 % SDS-PAGE gels,
and transferred to polyvinylidene fluoride membranes.
Western blots were analyzed using antibodies for c-myc
protein and β-actin (Cell signalling, USA). After washing
and developing using ECL kit (Thermo Scientific), the
protein bands were visualized.
Statistical analysis
All the experiments were conducted in duplicates and at
least three independent experiments. The data were cal-
culated and expressed as mean ± standard deviation
(SD). The analysis of variances (ANOVA) was calculated
among the groups followed by the Student’s t-test for
the differences between the groups. The level of signifi-
cance was computed and the values were considered
significant when p < 0.05.
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Results and discussion
MP contains 60–80 % humic matter (humic acid, fulvic
acid and humin), and rest of the content may be second-
ary metabolites from the plant and/or animal origin [6].
The presence of several contents might be due to the
plant/animal origin of MP or addition of various medi-
cinal plants (i.e. Ashwagandha, Triphala or Tulsi) during
the cooking process, which could augment the thera-
peutic properties of MP against various health com-
plaints. In the present study, we demonstrated the
anticancer properties of MP, by performing proliferation
and apoptosis assays.
MP inhibits cell proliferation
First, the effect of MP on cell proliferation and survival
was estimated. The cell proliferation assay was per-
formed using MTT assay. It is a NADPH-dependent cel-
lular oxidoreductase enzyme assay and produces
insoluble purple colour formazan, which represents the
numbers of the viable cells [20]. The insoluble crystals
are dissolved using DMSO and then quantitated. Upon
incubation of the cancer cells with MP, the proliferation
was significantly decreased and was directly proportional
to the increasing concentration of MP. There was a 55.8,
65.3, 70.3 and 73.3 % (p < 0.01) reduction in the cell pro-
liferation when the cells were incubated with 100, 200,
500 and 1000 μg/ml concentration of MP respectively
(Fig. 1a). The lower concentrations of MP did not have
any significant effects. Next, colony formation assay was
performed and found that the inhibition of cell number
was well correlated with the MTT assay (Fig. 1b). The
inhibition in the colony formation was indicated by the
observation of the blue coloured colonies, and the max-
imum inhibition was observed in the 1000 μg/ml (Fig. 1b,
viii), followed by 500 μg/ml (Fig. 1b, vii), 200 μg/ml
(Fig. 1b, vi) and 100 μg/ml (Fig. 1b, v) concentrations.
Both MTT assay and colony formation assay showed the
inhibition of Huh-7 cells by MP treatment, which indi-
cates its anti-proliferative properties in tumour cells.
MP induces apoptosis
Next, the effect of MP on inducing apoptosis was evalu-
ated as described in the Methods section. TUNEL assay
was performed to detect the for DNA fragmentation de-
tection, which could be a result of apoptosis [21]. The
apoptosis induction was increased with increasing con-
centrations of MP (Fig. 2a). The apoptotic and the total
cells were counted in at least 10 different high power
fields and the average of apoptotic cells were calculated.
The control cells were used as 1and the percent of the
apoptotic cells were found to be 21.7, 63, 77.3 and
80.1 % with the concentrations 100, 200, 500 and
1000 μg/ml of MP compared to the control untreated
cells (p < 0.01). While, the treatment of other concentra-
tions did not have any significant increase in the apop-
tosis (Fig. 2a and b). The apoptosis induction was
confirmed by Annexin V and PI exclusion assays. Two
different concentrations of MP (50 and 100 μg/ml) were
selected and the apoptosis induction was measured by
flow cytometry. Although there was a increase with MP
(50 μg/ml), significant increase was observed with
100 μg/ml of MP (Fig. 2c). These results confirm the
TUNEL assay findings.
Resistance to chemotherapy in tumour cells is due to
enhanced DNA repair capacity. HCC is considered to be
a tumour which is highly resistant to agents attacking
DNA. Several herbal composite formulas and natural
components (Curcumin, Resveratrol, and Silibinin) have
been shown to be beneficial for the cancer chemopre-
vention via inducing the DNA damage [22]. In the
present study, for the first time we have reported the
Fig. 1 Huh-7 cells (5,000 cells per well of 96-well plates) were cultured with different concentrations of MP for 24 h under serum-free conditions.
a MTT assay was performed and the percent of proliferation was calculated. In parallel experiments, curcumin (50 μM) was used as a positive
control (n = 3; #p < 0.05). b The colony formation assay was performed after plating cells in 60 mm dishes and incubating them with different
concentrations of MP for 6 days. After that the cells were stained with 0.5 % crystal violet and the colonies were visually observed. The representative
pictures show, untreated cells (i); cells treated with different concentrations of MP, 10 μg/ml (ii), 20 μg/ml (iii), 50 μg/ml (iv), 100 μg/ml (v), 200 μg/ml
(vi), 500 μg/ml (vii), and 1000 μg/ml (viii)
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anti-proliferative and pro-apoptotic properties of the MP
in hepatic cancer cells.
MP induces both ROS generation and NO production
The cells were incubated with different concentra-
tions of MP and the intracellular ROS levels and the
nitrite levels in the media were measured. There was
a 30, 38 and 49.8 % increase in ROS production in
the cells treated with 100, 200, and 500 μg/ml of MP
treatment respectively (Fig. 3a). Evidence supports
that oxidative stress-induced apoptosis may play an
important role in the anti-carcinogenic effect of sev-
eral chemopreventive agents (e.g. retinoids, nonsteroi-
dal anti-inflammatory drugs, polyphenols, tamoxifen,
vanilloids, and rotenoids) [23].
The Griess reagent is used to measure the level of NO
produced in the cells. Since NO is highly unstable and
gets converted to nitrite, the level of the nitrite was
measured with increasing concentrations of the MP. The
percentage of the NO production was 65.33, 61.2, 60.27,
51.26, 36 and 24.7 for 1000, 500, 200, 100, 50, and
20 μg/ml, reported respectively and these values were
statistically significant (p < 0.01) (Fig. 3b). NO may lead
to the cell death via inducing pro-apoptotic signals.
During the lack of respiration, mitochondrial membrane
potential is reduced, cytochrome c is released, the transi-
tion pores are opened and calcium is released by the in-
creased NO level which eventually leads to apoptosis [21].
Effect of MP on cellular antioxidants
To analyse the anti-oxidant levels in the cells, the cells
were cultured with different concentrations of MP and
the anti-oxidant levels were measured. The SOD activity
in Huh-7 cells was found to be decreasing with increas-
ing concentrations of MP. The SOD activity was found
to be significantly decreased by 20 and 34 % (p < 0.05)
Fig. 2 Huh-7 cells were cultured in 6-well plates and incubated with different concentrations of MP. a The cells were incubated with different
concentration of MP for 24 h and TUNEL assay was performed. The pictures are representative from three different experiments. (i) untreated control
cells, and (ii) 10 μg/ml, (iii) 20 μg/ml, (iv) 50 μg/ml, (v) 100 μg/ml, (vi) 200 μg/ml, (vii) 500 μg/ml and (viii) 1000 μg/ml of MP. b The positive cells were
counted in at least 10 different high power fields in three different experiments and the average was plotted as percent of control (n = 3; ##p < 0.01).
c To confirm the induction of apoptosis, cells were incubated with two different concentrations of MP (0, 50 and 100 μg/ml). The cells were collected
and Annexin V and PI exclusion assays were performed using Flow cytometry and the percent of apoptosis was calculated (n = 3; #p < 0.05)
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only with high concentrations, 500 μg/ml and 1000 μg/
ml, of MP respectively (Fig. 4a). The SOD activity was
not changed with other concentrations of the MP. Our
data showed that there was an increase in ROS produc-
tion in the cells due to the MP treatment. Hence, the
catalase activity was determined in these cells. The
catalase activity was significantly decreased in all the
concentrations of MP that was tested. There was a sig-
nificant reduction of 40, 38, 45, 51, 53 and 75 % of cata-
lase activity with the increasing concentrations of MP,
10, 20, 50, 100, 500, and 1000 μg/ml, respectively
(Fig. 4b). These results suggest that there is an increased
Fig. 3 Huh-7 cells were cultured in 6-well plates with different concentrations of MP. a The cells were stained with 10 μM DCF-DA and kept in
dark for 60 min. The cells were resuspended in PBS-EDTA solution and flow cytometry was performed to determine the ROS release. (i) untreated
control cells, and (ii) 10 μg/ml, (iii) 20 μg/ml, (iv) 50 μg/ml, (v) 100 μg/ml, (vi) 200 μg/ml and (vii) 500 μg/ml. b Nitric oxide release was measured
in terms of nitrite production using Griess reagent. After the incubation with different concentrations of MP, Griess reagent was added to the
medium and the nitrite formation was measured using Nitrate/nitrite colorimetric assay kit (Cayman). In parallel experiments, curcumin (50 μM)
was used as a positive control (n = 3; #p < 0.05 and ##p < 0.01)
Fig. 4 Huh-7 cells were cultured with different concentrations of MP for 24 h under serum-free conditions. After 24 h of treatment, SOD activity
(a), catalase activity (b), intracellular GSH levels (c), and intracellular MDA levels (as a marker of lipid peroxidation) (d) were measured as described
in Methods. The total cellular protein content was also measured and the results of the enzyme activity were expressed per mg protein (n = 3;
#p < 0.05 and ##p < 0.01)
Pant et al. BMC Complementary and Alternative Medicine  (2016) 16:148 Page 6 of 10
load of ROS levels in the cells incubated with MP. Next,
the glutathione production was measured in the MP-
treated cells. Glutathione production was significantly
increased with the increasing concentrations of MP.
There was a more than 7-fold increase of glutathione
production with 100, 500 and 1000 μg/ml of MP
(Fig. 4c).
Superoxide dismutase (SOD) converts superoxide into
H2O2 and O2. The catalase (CAT) enzyme catalyses the
decomposition of H2O2 to H2O and O2 [24]. These en-
zymes ensure that the cells effectively deal with ROS
and free radicals, induced oxidative stress. We demon-
strated that although MP simultaneously down-
regulated SOD, CAT and while GSH was up-regulated in
cancer cells, the cell death was increased. The falling
level of the cellular antioxidants may be a reason for the
augmented level of ROS in the cells.
The lipid peroxidation of the cancer cells was found to
be increased in concentration dependent manner. There
was a 2-fold increase with 50 and 100 μg/ml concentra-
tion of MP and there was a 3.3 fold increase in MDA
levels with 500 and 1000 μg/ml concentration of MP re-
spectively (Fig. 4d). It is the oxidative degradation of
lipids by free radicals and ROS which capture electrons
from the lipids of cell membranes, leading to the cell
damage and finally results in the apoptosis [23]. In this
study, we have clearly shown the in-vitro anti-cancer
properties of MP through generation of the ROS and
NO, which was accompanied by the lipid peroxidation-
induced apoptosis in hepatic cancer cells.
MP-induced ROS plays a role in proliferation and
apoptosis
To confirm whether ROS and NO play a role in prolifer-
ation and apoptosis, the cells were incubated with MP
(100 μg/ml) alone, or with NAC and L-NAME for 24 h.
MTT assay was performed and found that there is a sig-
nificant inhibition in proliferation (Fig. 5a). When the
cells were incubated with MP and NAC, there was a par-
tial recovery of the proliferation suggesting that ROS
might play a significant role in partly inhibiting the MP-
induced proliferation. When cells were incubated with
MP with L-NAME, although there was a slight increase
in proliferation, but was not significant. These data sug-
gest that nitric oxide alone might not be sufficient to be
responsible for the decreased proliferation, but may con-
tribute indirectly along with ROS in cells. Next, the role
of neutralizing ROS and NO on apoptosis was evaluated.
The cells were incubated with MP (100 μg/ml) alone, or
with NAC and L-NAME for 24 h. The cells were col-
lected and flow cytometry was used to analyse the
Annexin V and PI staining. There was a significant levels
of apoptosis was found in MP alone treated cells. MP-
induced apoptosis was recovered, at least in part, by the
addition of NAC, but addition of L-NAME did not result
in a significant recovery of apoptosis (Fig. 5b), suggesting
that NO alone might not have a significant role in MP-
induced apoptosis. It might exert its effect along with
ROS in these cells.
MP decreases the expression of miRNA-21 and increases
the expression of miRNA-22
Expression of miRNA-21 was found to be decreased
(85.5 % of control) significantly with the 100 μg/ml of
the MP as compared to the untreated control cells
(Fig. 6a). 50 μg/ml MP treated cells showed a 1.67 fold
increase and 100 μg/ml of MP treated cells showed the
1.6 fold increase in the expression of miRNA-22
(Fig. 6b).
miRNA-21 is a specific oncomiR (cancer specific
MiRNA), found more abundant in human cancers like
lung, pancreas, skin, liver, gastric, cervical, thyroid, and
various lymphatic and hematopoietic cancers. Inhibition
of miRNA-21 in HCC lines reduced the phenotypic be-
haviours of cancer cells (e.g. decreased cell proliferation,
migration and invasion). It contributes to the enhanced
aggressiveness of HCC and consequently results in poor
diagnosis in HCC patients. It induces the proliferation of
Fig. 5 Huh-7 cells were cultured with MP (0 and 100 μg/ml)
along with either NAC or L-NAME. a After 24 h of incubation,
the cell proliferation was estimated using MTT as described in
Methods (n = 3; *p < 0.05 compared to control; #p < 0.05
compared to MP 100 μg/ml). b The cells were incubated with
MP (100 μg/ml) along with NAC or L-NAME. Apoptosis
induction was determined using Annexin V and PI exclusion
assays All the experiments were performed in triplicates and
repeated at least three times (n = 3; *p < 0.05)
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cancer cells by the repressing the PTEN (a tumour sup-
pressor gene) [25]. Previously we have shown that over-
expression of miRAN-21 increases the proliferation in
heaptic cancer cells [18]. The data suggest that MP
might inhibit proliferation, at least in part, via inhibiting
miRNA-21 in these cells.
miRNA-22 has been observed as a tumour suppressing
agent in many cancers including HCC [26]. A known
target of miRNA-22 is histone deacetylase 4, which is
known to have many important functions in cancer de-
velopment and proliferation [26]. MP treatment lead to
the reduction of the miRNA-21 while it increased the
level of the miRNA-22 expression significantly, which
indicates the anti proliferative activities of MP via regu-
lating the epigenetic factors.
Over-expression of miRNA-22 decreases proliferation in
Huh-7 cells
MP treatment caused increased levels of miRNA-22. To
test whether over-expression results in decreased prolif-
eration, we incubated cells with non-specific miRNA,
which is shown not to inhibit any known mRNA, or
miRNA-22 preimiRs for 72 h. In parallel experiments, to
check the efficiency of the transfection, the cells were
Fig. 6 Huh-7 cells were culture in 6-well plates with different concentrations of MP (0, 50 and 100 μg/ml). After 24 h of incubation, the cells were
collected, total RNA enriched with miRNAs were isolated, cDNA was synthesized and real time RT-PCR for miRNA-21 (a) and miRNA-22 (b) was
performed as described in Methods. 5S RNA was used as internal control in all these real time PCR experiments. All the experiments were
performed in triplicates and repeated at least three times (n = 3; #p < 0.05 and ##p < 0.01)
Fig. 7 Huh-7 cells were culture in 6-well plates and transfected with either fluorescein-conjugated siRNA, non-specific miRNA (NS-miRNA) or
miRNA-22 for 72 h as described in Methods. a The cells were observed under the fluorescent microscope (i) and the same field was observed
under phase-contrast microscope (ii). b Total RNA was isolated, cDNA was synthesized and real time RT-PCR was performed for miRNA-22 and 5S
RNA. The relative expression was calculated and presented (n = 3; p < 0.001). c MiRNA-22 over-expressing cells were analyzed for the proliferation
assay using MTT (n = 3; p < 0.01). d The total cellular protein was isolated from miRNA-22 over expressing cells and Western blot was performed
for c-myc and b-actin protein. The picture is a representative of three experiments. Lane 1, control; lane 2, NS-miRNA; lane 3, miRNA-22
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transfected with fluorescein conjugated siRNA under
similar conditions. The results showed more than 75 %
of the cells were transfected with the siRNA (Fig. 7ai)
and corresponding phase-contrast image has been
shown (Fig. 7a, ii). To check the intracellular levels of
miRNA-22 after the transfection experiments, the cells
were collected, total RNA enriched with miRNAs were
isolated, cDNA was synthesized and real time PCR was
performed using miRNA-22 primers or 5S RNA, as con-
trol. The relative expression was calculated and the re-
sults show that there is a significant increase in miRNA-
22 in the transfected cells (Fig. 7b). Next, its role on the
proliferation was studied by MTT assay. The cells were
plated with or without miRNA-22 or with NS-miRNA.
The cell proliferation was estimated and found that
there was a 4.9 fold decrease in miRNA-22 transfected
cells (Fig. 7c). Next, we studied one of its target proteins,
c-myc, expression in these cells. Hence, the transfected
cells were isolated for the total cellular protein and
Western blots were performed for c-myc and β-actin, as
a loading control. The results showed that there was a
60 % reduction in the c-myc protein levels in the
miRNA-22 transfected cells (Fig. 7d). These results con-
firm that MP-induced miRNA-22 is partly responsible
for decreased proliferation in hepatic cells. Recently it
has been shown that miRNA-22 inhibits tumor growth
and metastasis in gastric cancer [27]. Another study also
has shown that miRNA-22 is a tumor suppressor [28]
confirming that our results are well correlated with
others findings. Hence, the data from this study suggests
that MP inhibits proliferation more than one pathways
in hepatic cancer cells. MP induces ROS and nitric
oxide, enhances the expression of miRNA-22 and de-
creases the expression of miRNA-21, a known onco-
miR. The enhanced apoptosis could be due to the in-
creased ROS, although nitric oxide might not play alone
in inducing apoptosis, along with increased ROS, it
might have an added effect to induce apoptosis in hep-
atic cancer cells.
Throughout the centuries of herbal and natural medi-
cinal practice, there are a number of candidate drugs de-
rived from the herbs or herbal compounds for
chemotherapeutic approach against HCC. Certain herbal
compounds have been found as an anti-HCC agent and
are successfully in use for cancer therapy. In this manu-
script we have shown that MP could be developed as a
potential natural chemotherapeutic agent.
Conclusion
MP vastly used in western Nepal and Kumaun (India), for a
number of health complaints. In our study, MP had shown
as potential anti-proliferative and pro-apoptotic properties
via ROS and NO, as well as by modulating the expression
levels of miRNA-21 and miRNA-22 (Fig. 8). The evidence
from the present study suggests that MP may be a factor in
diet that may lower the risk of cancer and may inhibit the
tumour growth. MP has been consumed for centuries by
the people for a variety of purposes. Our study for the first
time provides an evidence that proliferation, apoptosis, oxi-
dative stress and miRNAs are regulated by MP.
Abbreviations
CAT, Catalase; DCFDA, 2’,7’ dichloro-fluorescein diacetate; DMSO, Dimethyl
sulfoxide; L-NAME, L-NG-Nitroarginine methyl ester; MDA, malondialdehyde;
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NAC, N-acetyl
cysteine; NO, Nitric oxide; PBS, Phosphate buffer saline; ROS, Reactive oxygen
species; RT-PCR, Real time PCR; SOD, Superoxide dismutase; TUNEL, Terminal
deoxynucleotidyl transferase dUTP nick end labelling.
Acknowledgements
We would like to thank the local ethnic people of far western Nepal for
providing us the mineral pitch. We also express our gratitude to Mr. Nitin
Sharma and Mr. Milind Dongardive for providing technical help.
Funding
The study was partly supported by extramural grants from Department of
Biotechnology, Government of India, India and partly from the intramural
funds provided by South Asian University, New Delhi, India.
Availability of data and materials
All the data that are pertinent to the manuscript have been included in the
main text and in figures. No additional or supplementary data is available.
Authors' contributions
KP and SKV designed the study and drafted the manuscript. KP collected the
mineral pitch from Nepal. KP also performed some of the cell culture and
most of the Western blots. Most of the cell culture experiments and other
experiments are performed by PG, AKY, AG and AA. PD has done all the
miRNA-22 over-expression experiments. KP has written the manuscript and
SKV interpreted the data as well as corrected the manuscript. All authors
have read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Yes, we do give full consent for publication.
Fig. 8 Illustration shows the overall mechanism by which MP could
exert its anticancer activity in the hepatic cancer cells
Pant et al. BMC Complementary and Alternative Medicine  (2016) 16:148 Page 9 of 10
Ethics approval and consent to paticipate
This study only had used the cell lines for all the experiments. Hence no
animals or humans were used. No ethics approval is needed and not
relevant.
Received: 7 January 2016 Accepted: 18 May 2016
References
1. Thomas M. Molecular targeted therapy for hepatocellular carcinoma.
J Gastroenterol. 2009;44 Suppl 19:136–41.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer
J Clin. 2005;55(2):74–108.
3. Ling CQ, Wang LN, Wang Y, Zhang YH, Yin ZF, Wang M, Ling C. The
roles of traditional Chinese medicine in gene therapy. J Integr Med.
2014;12(2):67–75.
4. Ling CQ, Yue XQ, Ling C. Three advantages of using traditional Chinese
medicine to prevent and treat tumor. J Integr Med. 2014;12(4):331–5.
5. Agarwal SP, Khanna R, Karmarkar R, Anwer MK, Khar RK. Shilajit: a review.
Phytother Res. 2007;21(5):401–5.
6. Wilson E, Rajamanickam GV, Dubey GP, Klose P, Musial F, Saha FJ, Rampp T,
Michalsen A, Dobos GJ. Review on shilajit used in traditional Indian
medicine. J Ethnopharmacol. 2011;136(1):1–9.
7. Ghosal S. Chemistry of Shilajit, an immunomodulatory Ayurvedic rasayan.
Pure Appl Chem. 1990;62(7):1285–8.
8. Aryal MP, Berg A, Ogle B. Uncultivated plants and livelihood support: A case
study from the Chepang people of Nepal. Ethnobotany Res App. 2009;7:
409–22.
9. Yang HL, Hseu YC, Hseu YT, Lu FJ, Lin E, Lai JS. Humic acid induces
apoptosis in human premyelocytic leukemia HL-60 cells. Life Sci. 2004;
75(15):1817–31.
10. Ting HC, Yen CC, Chen WK, Chang WH, Chou MC, Lu FJ. Humic acid
enhances the cytotoxic effects of arsenic trioxide on human cervical cancer
cells. Environ Toxicol Pharmacol. 2010;29(2):117–25.
11. Hseu YC, Wang SY, Chen HY, Lu FJ, Gau RJ, Chang WC, Liu TZ, Yang HL.
Humic acid induces the generation of nitric oxide in human umbilical vein
endothelial cells: stimulation of nitric oxide synthase during cell injury. Free
Radic Biol Med. 2002;32(7):619–29.
12. Cagno V, Donalisio M, Civra A, Cagliero C, Rubiolo P, Lembo D. In vitro
evaluation of the antiviral properties of Shilajit and investigation of its
mechanisms of action. J Ethnopharmacol. 2015;166:129–34.
13. Eskandani M, Hamishehkar H, Ezzati Nazhad Dolatabadi J. Cytotoxicity and
DNA damage properties of tert-butylhydroquinone (TBHQ) food additive.
Food Chem. 2014;153:315–20.
14. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic
assay of cells in vitro. Nat Protoc. 2006;1(5):2315–9.
15. Yoon S, Kim TH, Natarajan A, Wang SS, Choi J, Wu J, Zern MA, Venugopal
SK. Acute liver injury upregulates microRNA-491-5p in mice, and its
overexpression sensitizes Hep G2 cells for tumour necrosis factor-alpha-
induced apoptosis. Liver Int. 2010;30(3):376–87.
16. Khan MA, Chen HC, Wan XX, Tania M, Xu AH, Chen FZ, Zhang DZ.
Regulatory effects of resveratrol on antioxidant enzymes: a mechanism
of growth inhibition and apoptosis induction in cancer cells. Mol Cells.
2013;35(3):219–25.
17. Khynriam D, Prasad SB. Changes in endogenous tissue glutathione level in
relation to murine ascites tumor growth and the anticancer activity of
cisplatin. Braz J Med Biol Res. 2003;36(1):53–63.
18. Damania P, Sen B, Dar SB, Kumar S, Kumari A, Gupta E, Sarin SK, Venugopal SK.
Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in
hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4)
and phosphatase and tensin homologue (PTEN). PLoS One. 2014;9(3), e91745.
19. Kumar S, Gupta P, Khanal S, Shahi A, Kumar P, Sarin SK, Venugopal SK.
Overexpression of microRNA-30a inhibits hepatitis B virus X protein-induced
autophagosome formation in hepatic cells. FEBS J. 2015;282(6):1152–63.
20. Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology: new
insights into their cellular reduction. Biotechnol Annu Rev. 2005;11:127–52.
21. Brune B. Nitric oxide: NO apoptosis or turning it ON? Cell Death Differ. 2003;
10(8):864–9.
22. Li Y, Martin 2nd RC. Herbal medicine and hepatocellular carcinoma:
applications and challenges. Evid Based Complement Alternat Med. 2011;
2011:541209.
23. Gago-Dominguez M, Jiang X, Castelao JE. Lipid peroxidation, oxidative
stress genes and dietary factors in breast cancer protection: a hypothesis.
Breast Cancer Res. 2007;9(1):201.
24. Khan MA, Tania M, Zhang DZ, Chen HC. Antioxidant enzymes and cancer.
Chin J Cancer Res. 2010;22(2):87–92.
25. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T.
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene
in human hepatocellular cancer. Gastroenterology. 2007;133(2):647–58.
26. Zhang J, Yang Y, Yang T, Liu Y, Li A, Fu S, Wu M, Pan Z, Zhou W. microRNA-
22, downregulated in hepatocellular carcinoma and correlated with
prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer.
2010;103(8):1215–20.
27. Zuo QF, Cao LY, Yu T, Gong L, Wang LN, Zhao YL, Xiao B, Zou QM.
MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by
directly targeting MMP14 and Snail. Cell Death Dis. 2015;6, e2000.
28. Zhang S, Zhang D, Yi C, Wang Y, Wang H, Wang J. MicroRNA-22 functions
as a tumor suppressor by targeting SIRT1 in renal cell carcinoma. Oncol
Rep. 2016;35(1):559–67.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Pant et al. BMC Complementary and Alternative Medicine  (2016) 16:148 Page 10 of 10
